SMAD3 and breast cancer: We showed that blocking the function of TMEPAI in MDA-MB-231 breast cancer cells strongly suppressed the formation of metastatic foci in lungs of mice [15], thus supporting our Smad3-TMEPAI-PTEN axis hypothesis in triple negative breast cancer progression.